At its widest point, the tiny device is just 5 millimeters wide. One end is curled into a cuff that softly wraps around a single nerve, bypassing the need for sutures.
New device could provide an alternative to opioids and other highly addictive drugs
A Northwestern University-led team of researchers has developed a small, soft, flexible implant that relieves pain on demand and without the use of drugs. The first-of-its-kind device could provide a much-needed alternative to opioids and other highly addictive medications.
The biocompatible, water-soluble device works by softly wrapping around nerves to deliver precise, targeted cooling, which numbs nerves and blocks pain signals to the brain. An external pump enables the user to remotely activate the device and then increase or decrease its intensity. After the device is no longer needed, it naturally absorbs into the body — bypassing the need for surgical extraction.
The researchers believe the device will be most valuable for patients who undergo routine surgeries or even amputations that commonly require post-operative medications. Surgeons could implant the device during the procedure to help manage the patient’s post-operative pain.
“Although opioids are extremely effective, they also are extremely addictive,” said Northwestern’s John A. Rogers, who led the device’s development. “As engineers, we are motivated by the idea of treating pain without drugs — in ways that can be turned on and off instantly, with user control over the intensity of relief. The technology reported here exploits mechanisms that have some similarities to those that cause your fingers to feel numb when cold. Our implant allows that effect to be produced in a programmable way, directly and locally to targeted nerves, even those deep within surrounding soft tissues.”
A bioelectronics pioneer, Rogers is the Louis Simpson and Kimberly Querrey Professor of Materials Science and Engineering, Biomedical Engineering and Neurological Surgery in the McCormick School of Engineering and Northwestern University Feinberg School of Medicine. He also is the founding director of the Querrey Simpson Institute for Bioelectronics. Jonathan Reeder, a former postdoctoral fellow in Rogers’ laboratory, is the paper’s first author.
How it works
Although the new device might sound like science fiction, it leverages a simple, common concept that everyone knows: evaporation. Similar to how evaporating sweat cools the body, the device contains a liquid coolant that is induced to evaporate at the specific location of a sensory nerve.
“As you cool down a nerve, the signals that travel through the nerve become slower and slower — eventually stopping completely,” said study coauthor Dr. Matthew MacEwan of Washington University School of Medicine in St. Louis. “We are specifically targeting peripheral nerves, which connect your brain and your spinal cord to the rest of your body. These are the nerves that communicate sensory stimuli, including pain. By delivering a cooling effect to just one or two targeted nerves, we can effectively modulate pain signals in one specific region of the body.”
“As engineers, we are motivated by the idea of treating pain without drugs — in ways that can be turned on and off instantly, with user control over the intensity of relief.” — John A. Rogers
To induce the cooling effect, the device contains tiny microfluidic channels. One channel contains the liquid coolant (perfluoropentane), which is already clinically approved as an ultrasound contrast agent and for pressurized inhalers. A second channel contains dry nitrogen, an inert gas. When the liquid and gas flow into a shared chamber, a reaction occurs that causes the liquid to promptly evaporate. Simultaneously, a tiny integrated sensor monitors the temperature of the nerve to ensure that it’s not getting too cold, which could cause tissue damage.
“Excessive cooling can damage the nerve and the fragile tissues around it,” Rogers said. “The duration and temperature of the cooling must therefore be controlled precisely. By monitoring the temperature at the nerve, the flow rates can be adjusted automatically to set a point that blocks pain in a reversible, safe manner.”
Precision power
While other cooling therapies and nerve blockers have been tested experimentally, all have limitations that the new device overcomes. Previously researchers have explored cryotherapies, for example, which are injected with a needle. Instead of targeting specific nerves, these imprecise approaches cool large areas of tissue, potentially leading to unwanted effects such as tissue damage and inflammation.
At its widest point, Northwestern’s tiny device is just 5 millimeters wide. One end is curled into a cuff that softly wraps around a single nerve, bypassing the need for sutures. By precisely targeting only the affected nerve, the device spares surrounding regions from unnecessary cooling, which could lead to side effects.
“You don’t want to inadvertently cool other nerves or the tissues that are unrelated to the nerve transmitting the painful stimuli,” MacEwan said. “We want to block the pain signals, not the nerves that control motor function and enables you to use your hand, for example.”
Previous researchers also have explored nerve blockers that use electrical stimulation to silence painful stimuli. These, too, have limitations.
“You can’t shut down a nerve with electrical stimulation without activating it first,” MacEwan said. “That can cause additional pain or muscle contractions and is not ideal, from a patient’s perspective.”
Disappearing act
This new technology is the third example of bioresorbable electronic devices from the Rogers lab, which introduced the concept of transient electronics in 2012, published in Science. In 2018, Rogers, MacEwan and colleagues demonstrated the world’s first bioresorbable electronic device — a biodegradable implant that speeds nerve regeneration, published in Nature Medicine. Then, in 2021, Rogers and colleagues introduced a transient pacemaker, published in Nature Biotechnology.
All components of the devices are biocompatible and naturally absorb into the body’s biofluids over the course of days or weeks, without needing surgical extraction. The bioresorbable devices are completely harmless — similar to absorbable stitches.
At the thickness of a sheet of paper, the soft, elastic nerve cooling device is ideal for treating highly sensitive nerves.
“If you think about soft tissues, fragile nerves and a body that’s in constant motion, any interfacing device must have the ability to flex, bend, twist and stretch easily and naturally,” Rogers said. “Furthermore, you would like the device to simply disappear after it is no longer needed, to avoid delicate and risky procedures for surgical removal.”
Original Article: Dissolving implantable device relieves pain without drugs
More from: Northwestern University | Robert R. McCormick School of Engineering and Applied Science | Northwestern University Feinberg School of Medicine | Washington University School of Medicine
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Bioresorbable electronic devices
- High Performance Medical Plastic Market Set to Reach US$ 2.4 Billion by 2034, Anticipated Surge at 8.1% CAGR
The market is anticipated to reach US$ 2.4 billion by 2034. The market is further expected to surge at a CAGR of 8.1% during by 2034.
- 10 Must-Know Tips for Cleaning Every Electronic Device the Right Way
Spring clean your often-used devices without damaging them. We have tips for your phone, tablet, laptop, headphones, smartwatch, fitness tracker, game controller, and more. My title is Senior ...
- Aerogel-based phase change materials improve thermal management, reduce microwave emissions in electronic devices
Electronic devices are getting more and more complex as they are built to carry out an ever-increasing number of functions. This can be seen in the increased functionality in our personal devices such ...
- Projected Surge: Bioresorbable Polymers Market Set to Reach US$ 3,937.8 Million by 2033 with 10.9% CAGR
The bioresorbable polymers market is forecasted to garner revenue of US$ 3,937.8 million in 2033, up from US$ 1,339.4 million in 2023 advancing at a rate of 10.9% from 2023 to 2033. The market for ...
- Analog Devices
and motion into electrical signals to be used in a wide array of electronic devices. We focus on key strategic markets where our signal processing technology is often a critical differentiator in ...
Go deeper with Google Headlines on:
Bioresorbable electronic devices
[google_news title=”” keyword=”bioresorbable electronic devices” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Treating pain without drugs
- Lexi had surgery for obesity at 12. Now she could be facing a lifetime on weight-loss drugs
One in five children and adolescents in the United States are affected by obesity. And parents are turning to radical treatments like surgery and weight-loss drugs.
- Psilocybin for chronic pain? Preliminary research sheds light on psychedelic’s potential
Researchers at the University of Michigan found that psilocybin significantly reduced chronic touch-related pain in rats without affecting heat-related pain. The pain relief outlasted the drug's ...
- 11 drugs now in shortage
Here are 11 new shortages, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor's note: The drugs are listed in alphabetical order.
- Non-Opioid Pain Treatment Market CAGR of 18%, Navigating Tomorrow, The Future of Market Size and Opportunities
Non-Opioid Pain Treatment Market is valued at approximately USD 13.8 million in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027.
- Ex-Scottsbluff police captain who stole drugs for opioid addiction sentenced
Brian Wasson, a former captain with the Scottsbluff Police Department, was sentenced to prison for felony theft of drug evidence.
Go deeper with Google Headlines on:
Treating pain without drugs
[google_news title=”” keyword=”treating pain without drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]